Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05924971 · ClinicalTrials.gov registry record · Phase 2
Aspirin for Postpartum Patients With Preeclampsia
A Phase 2 study of Preeclampsia Postpartum, sponsored by MemorialCare Health System.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 86
- Enrollment target
- 1
- Study location
NCT05924971 is a Phase 2 study of Preeclampsia Postpartum that is actively recruiting participants, run by MemorialCare Health System. The registered enrollment target is 86 participants, above the 63-participant average among 8 other Preeclampsia Postpartum trials with a reported enrollment target (37% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05924971, a Phase 2 study of Preeclampsia Postpartum, is actively recruiting participants, sponsored by MemorialCare Health System.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 86 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to evaluate the effect of low-dose aspirin on recovery from severe preeclampsia (a high blood pressure disorder of pregnancy) among women who have given birth. We hypothesize that taking aspirin for the first week after giving birth will enhance recovery from preeclampsia by decreasing the levels of a protein called soluble fms-like tyrosine kinase (sFlt-1), which is thought to be a main contributor to the development of preeclampsia, and speeding up return to a normal blood pressure.
Conditions Studied
Interventions
- DRUG Aspirin 81Mg Ec Tab
Study Locations (1)
California
- Miller Children's and Women's Hospital, Long Beach/MemorialCare Long Beach - Long Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2023-07-26 |
| Est. Completion | 2026-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05924971
The ClinicalTrials.gov registry entry for NCT05924971 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 86 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 63-participant average among 8 other Preeclampsia Postpartum trials with a reported enrollment target (37% higher). The listed sponsor is MemorialCare Health System, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Preeclampsia Postpartum appearing as the primary indexed condition, and to 1 intervention - of which Aspirin 81Mg Ec Tab is the first listed.
NCT05924971 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05924971 about?
NCT05924971 is a clinical study titled "Aspirin for Postpartum Patients With Preeclampsia". The purpose of this research study is to evaluate the effect of low-dose aspirin on recovery from severe preeclampsia (a high blood pressure disorder of pregnancy) among women who have given birth. We hypothesize that taking aspirin for the first week after giving birth will enhance recovery from pr...
What is the current status of trial NCT05924971?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 86 participants. The study started on 2023-07-26. Estimated completion is 2026-12.
What conditions does trial NCT05924971 study?
This clinical trial studies the following conditions: Preeclampsia Postpartum.
What interventions are being tested in trial NCT05924971?
The interventions under investigation include: Aspirin 81Mg Ec Tab (DRUG).
Who is sponsoring clinical trial NCT05924971?
This trial is sponsored by MemorialCare Health System, which has 21 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05924971 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Preeclampsia Postpartum
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Postpartum Low-Dose Aspirin and Preeclampsia
RECRUITING · Phase 2
-
Sensitivity of Angiotensin II Type II Receptors in Women Following Preeclampsia
RECRUITING · Early Phase 1
-
Aspirin and Preeclampsia
RECRUITING · Phase 4
-
Vascular Effects of High-Salt After Preeclampsia
RECRUITING · Early Phase 1
-
Preeclampsia Educational Program Study (PrEPS)
ACTIVE NOT RECRUITING · NA
-
MR and Inflammation After Preeclampsia
ACTIVE NOT RECRUITING · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.